[Federal Register Volume 80, Number 222 (Wednesday, November 18, 2015)]
[Notices]
[Pages 72077-72078]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-29382]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed Collection; 60-Day Comment Request; The National 
Physician Survey of Precision Medicine in Cancer Treatment (NCI)

    Summary: In compliance with the requirement of Section 
3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity 
for public comment on proposed data collection projects, the National 
Cancer Institute, the National Institutes of Health (NIH) will publish 
periodic summaries of proposed projects to be submitted to the Office 
of Management and Budget (OMB) for review and approval.
    Written comments and/or suggestions from the public and affected 
agencies are invited to address one or more of the following points: 
(1) Whether the proposed collection of information is necessary for the 
proper performance of the function of the agency, including whether the 
information will have practical utility; (2) The accuracy of the 
agency's estimate of the burden of the proposed collection of 
information, including the validity of the methodology and assumptions 
used; (3) The quality, utility, and clarity of the information to be 
collected; and (4) Minimize the burden of the collection of information 
on those who are to respond, including the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology.
    To Submit Comments and For Further Information: To obtain a copy of 
the data collection plans and instruments, submit comments in writing, 
or request more information on the proposed project, contact: Janet S. 
de Moor, Ph.D., MPH, Project Officer, Division of Cancer

[[Page 72078]]

Control and Population Sciences, 9609 Medical Center Drive, 3E438, MSC 
9764, Rockville, MD, 20850 or call non-toll-free number 240-276-6806 or 
Email your request, including your address to: [email protected]. 
Formal requests for additional plans and instruments must be requested 
in writing.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 60 days 
of the date of this publication.
    Proposed Collection: The National Physician Survey of Precision 
Medicine in Cancer Treatment 0925-NEW, National Cancer Institute (NCI), 
National Institutes of Health (NIH).
    Need and Use of Information Collection: The purpose of this study 
is to investigate the current practice of precision medicine in cancer 
treatment among medical oncologists in the U.S. This is a nationally 
representative survey designed to assess oncologists' current and 
potential use of genomic testing, to inform the development of 
interventions to facilitate optimal use of genomic testing and to 
improve patient-physician discussions of the risks, possible benefits, 
and uncertainties surrounding the use of these tests. Current knowledge 
of this topic is limited as there are no nationally-representative 
studies on this topic to date. There are only two non-federal studies 
two that have examined physicians' knowledge and attitudes regarding 
somatic genetic and genomic testing. The survey will be administered by 
mail and web to approximately 1,630 oncology physicians across the U.S. 
Non-respondents will be invited to complete a follow-back survey to 
share their reasons for not participating. The study findings will 
inform NCI of relevant issues and concerns relating to the application 
of precision medicine to current and future cancer treatment patterns 
and practice. This information will also inform the development of new 
funding initiatives to optimize the use of precision medicine in cancer 
treatment. Additionally, information collected as part of this survey 
will be used to develop physician educational materials to address 
barriers to precision medicine in cancer care delivery.
    OMB approval is requested for 2 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 261.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
           Form name                 Type of         Number of     responses per   per response    Total annual
                                   respondent       respondents     respondent      (in hours)      burden hour
----------------------------------------------------------------------------------------------------------------
Precision Medicine Survey--     Oncology                     175               1           20/60              58
 Pilot Study.                    Physicians.
Precision Medicine Survey--     Oncology                     600               1           20/60             200
 Full Study.                     Physicians.
Follow-back Survey............  Oncology                      40               1            5/60               3
                                 Physicians.
----------------------------------------------------------------------------------------------------------------


    Dated: October 28, 2015.
Karla Bailey,
Project Clearance Liaison, NCI, NIH.
[FR Doc. 2015-29382 Filed 11-17-15; 8:45 am]
 BILLING CODE 4140-01-P